Previous reports showed that the abnormal activation of the PPARγ and related signaling events contributed to the overexpression of retinoid X receptors (RXRs) during luminal bladder tumor initiation and progression (Rochel et al., 2019). The gene discussed is PPARG; the disease is urinary bladder neoplasm.